Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice.
about
Smoking tobacco along with marijuana increases symptoms of cannabis dependenceHarm reduction--the cannabis paradoxEndocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibitionNew mechanisms and perspectives in nicotine withdrawalRemoval of continuous nicotine infusion produces somatic but not behavioral signs of withdrawal in mice.Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ miceRole of CB2 cannabinoid receptors in the rewarding, reinforcing, and physical effects of nicotineInvolvement of metabotropic glutamate receptor 5 in brain reward deficits associated with cocaine and nicotine withdrawal and somatic signs of nicotine withdrawal.Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system.The role of fatty acid amide hydrolase inhibition in nicotine reward and dependence.Inhibition of monoacylglycerol lipase reduces nicotine withdrawalRole of the endogenous cannabinoid system in nicotine addiction: novel insights.Marijuana use and tobacco smoking cessation among heavy alcohol drinkers.Role of α7- and β4-containing nicotinic acetylcholine receptors in the affective and somatic aspects of nicotine withdrawal: studies in knockout mice.Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapseGenetic and pharmacological approaches to evaluate the interaction between the cannabinoid and cholinergic systems in cognitive processes.Influence of δ-opioid receptors in the behavioral effects of nicotine.Decreased withdrawal symptoms but normal tolerance to nicotine in mice null for the alpha7 nicotinic acetylcholine receptor subunitPredictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking statusAnimal models of nicotine exposure: relevance to second-hand smoking, electronic cigarette use, and compulsive smoking.Role of endocannabinoids in regulating drug dependence.The endocannabinoid system: a new molecular target for the treatment of tobacco addiction.The endogenous cannabinoid system modulates nicotine reward and dependence.Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders.A review of co-morbid tobacco and cannabis use disorders: possible mechanisms to explain high rates of co-use.Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives.Cannabinoid CB2 Receptor Mediates Nicotine-Induced Anti-Inflammation in N9 Microglial Cells Exposed to β Amyloid via Protein Kinase C.Interactions between nicotine and drugs of abuse: a review of preclinical findings.Neuropeptide systems and new treatments for nicotine addiction.Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior.Ecological momentary assessment of working memory under conditions of simultaneous marijuana and tobacco useEvaluation of a reduced nicotine product standard: Moderating effects of and impact on cannabis use[The endogenous opioid system and drug addiction].Influence of central nicotinic receptors on arachidonylcyclopropylamide (ACPA)-induced antinociception in mice.Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations.Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.Baclofen prevented the changes in c-Fos and brain-derived neutrophic factor expressions during mecamylamine-precipitated nicotine withdrawal in mice.Trends in Daily Cannabis Use Among Cigarette Smokers: United States, 2002-2014.
P2860
Q24650310-F868A70E-9E00-4480-BAA0-F6CFE1A0DC00Q24814542-B4795B87-2114-4B52-9CB7-D5D9F0637474Q27311588-86B8DB8A-0BA5-4375-A508-9437CD2EB283Q28111991-B13607D7-AA2F-4C33-90BA-6C5126BDD8C7Q30478971-FBAD9FA7-4B25-4981-826F-FF30071FE15FQ30489401-C8FE33A4-8306-4EEF-929E-A4F5CFDA19A1Q30551483-28E4C613-365B-492B-9774-548B3F1EA786Q33566228-827A6EC7-036E-43F5-B5C2-37DAAA37DEAEQ34012381-196C4CC0-B76B-41DC-AB7A-7A5CD21C226DQ34282073-8D715547-4FFF-46F4-A123-CD60048E6095Q34994542-11BD3B15-B7B3-4E54-9A11-B5669E2AE996Q35216481-0DEDCD08-A827-4E3F-A756-A594CE1C98B9Q35417708-A19039AA-9A71-4490-9286-65F8777E8100Q35831006-7EB72425-9D2D-4C1B-81AE-B5FD5324132DQ36024183-F48D434D-0961-46B4-8A65-0F2288D0A9C9Q36052527-BDB9530E-AB8D-4DEA-98CC-CD387CB0C0E0Q36174111-3BCBCE1A-3BB8-432E-88CD-9D2A70003D00Q36291492-C8FFE09E-5CE3-4726-AD28-CA2B91C0CAEEQ36468008-DF6F5DBD-F77B-4012-B97E-160102745E73Q36900018-8271877E-F2A7-4623-BABD-B6C830E3608DQ37129779-689FE3A1-D2A4-477B-B61B-CD70B7590958Q37291517-DBA26D82-59C9-4ED4-A6A5-300FB5ECD225Q37353755-6E2C69A3-D48F-4376-B834-C0AE6D5A9876Q37444808-1AF03FC0-BFCC-451C-AC65-86DE4DE17623Q38348213-804B1B72-7E0B-4438-916A-0925C2908732Q38686274-76EE9BAC-DD10-469B-8F2F-7465D374E85FQ38793610-8018ABC2-E51A-4480-9313-B0847347CEB7Q38824915-0EBBD24A-CB41-4F9B-83EB-01CBB39A82FFQ39059946-7CA1C0CA-DBB4-415C-99D8-6994C25F0915Q39299788-6237DEB4-3B85-46D9-A702-DCF49E3B39B3Q40012619-459B78AA-880B-4765-B40F-F230830F1AEEQ41640336-0EB4A666-FF26-42F7-93C6-567D38579BC8Q42325921-5715C971-223E-4236-99C9-A2C8058E1B32Q46716487-5A8C1968-F02F-4FB4-815B-5E57B564CD6EQ47914487-902F18AB-F781-4978-B30E-F7E98E9E9085Q48139928-F0309C54-5F55-410A-B252-E2124342E0DDQ48649471-ACFD8311-68E0-4CF0-9BF1-9A1F3935EFABQ52775809-6DD312BE-EA23-4209-8FA4-520E1CE81692
P2860
Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Delta9-tetrahydrocannabinol de ...... f nicotine withdrawal in mice.
@en
Delta9-tetrahydrocannabinol de ...... f nicotine withdrawal in mice.
@nl
type
label
Delta9-tetrahydrocannabinol de ...... f nicotine withdrawal in mice.
@en
Delta9-tetrahydrocannabinol de ...... f nicotine withdrawal in mice.
@nl
prefLabel
Delta9-tetrahydrocannabinol de ...... f nicotine withdrawal in mice.
@en
Delta9-tetrahydrocannabinol de ...... f nicotine withdrawal in mice.
@nl
P2093
P2860
P1476
Delta9-tetrahydrocannabinol de ...... f nicotine withdrawal in mice.
@en
P2093
Fernando Berrendero
Graciela N Balerio
Patricia Murtra
Rafael Maldonado
P2860
P304
P356
10.1111/J.1460-9568.2004.03714.X
P407
P50
P577
2004-11-01T00:00:00Z